4.5 Article

Beyond the sarcomere:: CSRP3 mutations cause hypertrophic cardiomyopathy

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Paxillin and ponsin interact in nascent costameres of muscle cells

Katja Gehmlich et al.

JOURNAL OF MOLECULAR BIOLOGY (2007)

Article Cardiac & Cardiovascular Systems

Reversal of calcium cycling defects in advanced heart failure -: Toward molecular therapy

Masahiko Hoshijima et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)

Article Cardiac & Cardiovascular Systems

The genetic bases of cardiomyopathies

Pascale Richard et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)

Meeting Abstract Cardiac & Cardiovascular Systems

Decreased levels of non-nuclear muscle LIM protein are associated with cardiac dysfunction and heart failure

S. Y. Boateng et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)

Article Cell Biology

Muscle LIM protein plays both structural and functional roles in skeletal muscle

IA Barash et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)

Article Biochemical Research Methods

HaploPainter:: a tool for drawing pedigrees with complex haplotypes

H Thiele et al.

BIOINFORMATICS (2005)

Article Cardiac & Cardiovascular Systems

Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants

A Sarikas et al.

CARDIOVASCULAR RESEARCH (2005)

Letter Endocrinology & Metabolism

W4R variant in CSRP3 encoding muscle LIM protein in a patient with hypertrophic cardiomyopathy

B Newman et al.

MOLECULAR GENETICS AND METABOLISM (2005)

Article Medicine, General & Internal

Glycogen storage diseases presenting as hypertrophic cardiomyopathy

M Arad et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Cardiac & Cardiovascular Systems

Cytoskeletal structure and recovery in single human cardiac myocytes

LA Aquila et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2004)

Article Cardiac & Cardiovascular Systems

Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy

SL Van Driest et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)

Article Endocrinology & Metabolism

Mutations in the muscle LIM protein and α-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis

B Mohapatra et al.

MOLECULAR GENETICS AND METABOLISM (2003)

Letter Cardiac & Cardiovascular Systems

What is the mechanism of abnormal blood pressure response on exercise in hypertrophic cardiomyopathy

R Campbell et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)

Article Cardiac & Cardiovascular Systems

Subclinical skeletal muscle abnormalities in patients with hypertrophic cardiomyopathy and their relation to clinical characteristics

A Anastasakis et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2003)

Article Cardiac & Cardiovascular Systems

Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy

C Geier et al.

CIRCULATION (2003)

Article Medicine, Research & Experimental

The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model

C Semsarian et al.

JOURNAL OF CLINICAL INVESTIGATION (2002)

Article Cardiac & Cardiovascular Systems

Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy

J Erdmann et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)

Article Biochemistry & Molecular Biology

Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy

K Elliott et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)

Article Cardiac & Cardiovascular Systems

Decreased expression of the cardiac LIM domain protein MLP in chronic human heart failure

O Zolk et al.

CIRCULATION (2000)